S
Overview
StartVim provides telehealth services to individuals and businesses through a nationwide online platform. It offers opioid use disorder treatment with medications like Suboxone, weight loss programs using GLP-1, hormone replacement therapy for menopause, and general urgent care delivered remotely. Patients access care via the online platform, receive remote consultations and online prescriptions, and can access employer-supported OUD treatment as a workplace benefit. The company's goal is to expand access to evidence-based, convenient online medical care for adults over 45 and to support employers with wellness benefits.
Work here?Claim your company
Simplify's Take
What believers are saying
- September 2026 jobs show active hiring for performance marketing and nurse practitioners.
- Employer-sponsored OUD treatment fits retention budgets and reduces absenteeism for HR teams.
- The September 2026 site refresh signals continuing demand generation and national expansion.
What critics are saying
- Meta and Google ad dependence exposes StartVim to rising CAC and policy bans.
- Employer GLP-1 coverage is shrinking in 2026, squeezing benefits sales and margins.
- DEA and state telehealth scrutiny can shut prescribing fast and wreck Suboxone growth.
What makes StartVim unique
- Ryan Das, M.D. anchors physician-led telehealth for adults over 45.
- StartVim combines DTC virtual care with employer-sponsored OUD benefits in one platform.
- Its lineup spans Suboxone, GLP-1 weight loss, hormone therapy, and urgent care.
Help us improve and share your feedback! Did you find this helpful?